Sirtuin 3 and Sirtuin 7 in Systemic Sclerosis
Systemic Sclerosis
About this trial
This is an interventional other trial for Systemic Sclerosis
Eligibility Criteria
Inclusion Criteria:
- Patients with systemic sclerosis diagnosed by 2013 ACR\EULAR classification criteria of systemic sclerosis
- Patients' age >18
- 25 rheumatoid arthritis patients as a control .
Exclusion Criteria:
-Overlap or mixed connective tissue diseases.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Other
Other
study group
control group
Blood sample ( 5 ml venous blood ) will be obtained under complete aseptic conditions from all eligible participants , using serum separator tube and allow samples to clot for 30 minutes before centrifugation for 15 minutes to obtain clear serum .Separated serum will be stored at < - 20c ( avoid repeated freeze - thaw cycles) till assessment of Sirt 3 and Sirt 7 levels using Enzyme- linked immunosorbent assay (ELISA) method .
Blood sample ( 5 ml venous blood ) will be obtained under complete aseptic conditions from all eligible participants , using serum separator tube and allow samples to clot for 30 minutes before centrifugation for 15 minutes to obtain clear serum .Separated serum will be stored at < - 20c ( avoid repeated freeze - thaw cycles) till assessment of Sirt 3 and Sirt 7 levels using Enzyme- linked immunosorbent assay (ELISA) method .